SG88783A1 - Steroid sulphatase inhibitors - Google Patents

Steroid sulphatase inhibitors

Info

Publication number
SG88783A1
SG88783A1 SG200003817A SG381792A SG88783A1 SG 88783 A1 SG88783 A1 SG 88783A1 SG 200003817 A SG200003817 A SG 200003817A SG 381792 A SG381792 A SG 381792A SG 88783 A1 SG88783 A1 SG 88783A1
Authority
SG
Singapore
Prior art keywords
sub
compound
steroid sulphatase
enzyme
sulphate
Prior art date
Application number
SG200003817A
Other languages
English (en)
Inventor
Michael John Reed
Barry Victor Lloyd Potter
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Publication of SG88783A1 publication Critical patent/SG88783A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Surgical Instruments (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG200003817A 1991-08-29 1992-08-28 Steroid sulphatase inhibitors SG88783A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919118478A GB9118478D0 (en) 1991-08-29 1991-08-29 Steroid sulphatase inhibitors

Publications (1)

Publication Number Publication Date
SG88783A1 true SG88783A1 (en) 2002-05-21

Family

ID=10700604

Family Applications (7)

Application Number Title Priority Date Filing Date
SG200207238A SG115508A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200207232A SG106116A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200003817A SG88783A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200207242A SG103374A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG1996005394A SG73391A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200003815A SG88782A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200003816A SG103820A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SG200207238A SG115508A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200207232A SG106116A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors

Family Applications After (4)

Application Number Title Priority Date Filing Date
SG200207242A SG103374A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG1996005394A SG73391A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200003815A SG88782A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors
SG200003816A SG103820A1 (en) 1991-08-29 1992-08-28 Steroid sulphatase inhibitors

Country Status (26)

Country Link
US (3) US5616574A (uk)
EP (6) EP0921130B1 (uk)
JP (6) JP3219408B2 (uk)
KR (4) KR100258396B1 (uk)
AT (5) ATE278704T1 (uk)
AU (2) AU689043B2 (uk)
BR (1) BR9206434A (uk)
CA (4) CA2305758A1 (uk)
CY (4) CY2253B1 (uk)
CZ (1) CZ295939B6 (uk)
DE (5) DE69233020T2 (uk)
DK (4) DK0921130T3 (uk)
ES (4) ES2193475T3 (uk)
FI (5) FI940903A (uk)
GB (1) GB9118478D0 (uk)
GE (6) GEP20063773B (uk)
GR (1) GR3034579T3 (uk)
HK (3) HK1019753A1 (uk)
HU (1) HUT66097A (uk)
LV (1) LV12618B (uk)
NO (6) NO307301B1 (uk)
RU (4) RU2210574C2 (uk)
SG (7) SG115508A1 (uk)
SK (4) SK282189B6 (uk)
UA (4) UA41875C2 (uk)
WO (1) WO1993005064A1 (uk)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
GB9604709D0 (en) * 1996-03-05 1996-05-01 Imperial College A compound
US6083978A (en) * 1996-03-05 2000-07-04 Sterix Limited Compounds with a sulfamate group
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6011024A (en) * 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6903084B2 (en) * 1991-08-29 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
ES2201101T3 (es) * 1994-04-05 2004-03-16 Celltech Therapeutics Limited Uso de inhibidores de sulfatasas de esteroides.
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE4447714C2 (de) * 1994-08-09 1998-02-05 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur Hormonsubstitutions-Therapie
GB9422777D0 (en) * 1994-11-11 1995-01-04 Imperial College Assay
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5705495A (en) * 1995-10-19 1998-01-06 Jenapharm Gmbh & Co. Kg. Sulfamate derivatives of 1,3,5(10)-estratriene derivatives, methods for their production and pharmaceuticals containing these compounds
US6921776B1 (en) 1996-02-16 2005-07-26 Sterix Limited Compound
US6506792B1 (en) 1997-03-04 2003-01-14 Sterix Limited Compounds that inhibit oestrone sulphatase and/or aromatase and methods for making and using
CA2266051A1 (en) * 1996-09-12 1998-03-19 Teikoku Hormone Mfg. Co., Ltd. 3-substituted-d-homo-1,3,5,(10)-estratriene derivatives
US6642220B1 (en) * 1996-12-05 2003-11-04 Sterix Limited Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same
US20040127473A1 (en) * 1996-12-05 2004-07-01 Reed Michael John Compound
US5763432A (en) * 1997-01-29 1998-06-09 Sri International Steriod inhibitors of estrone sulfatase and associated pharmaceutical compositions and methods of use
DE19712488A1 (de) 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
GB9708716D0 (en) * 1997-04-29 1997-06-18 Imperial College Chronic heart failure
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6288050B1 (en) * 1997-07-18 2001-09-11 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
US6376687B1 (en) 1997-07-18 2002-04-23 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same
GB2331987B (en) * 1997-12-04 2002-11-27 Imperial College Polycyclic sulphamate inhibitors of oestrone sulphatase
GB2331988B (en) 1997-12-04 2003-04-16 Imperial College Polycyclic sulphamate inhibitors or oestrone sulphatase
US6046186A (en) * 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
GB9807779D0 (en) 1998-04-09 1998-06-10 Ciba Geigy Ag Organic compounds
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
ES2310943T3 (es) 1998-06-10 2009-01-16 Sterix Limited Composicion farmaceutica con factor de necrosis tumoral a y 2-metoxiestrona-3-o-sulfamato para la inhibicion de la estrona sulfatasa.
US6248780B1 (en) * 1998-10-01 2001-06-19 Duquesne University Of The Holy Ghost Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
WO2000053620A1 (fr) * 1999-03-10 2000-09-14 Nippon Organon K. K. Nouveaux derives d'oestradiol
JP2000309599A (ja) 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
IL145995A0 (en) * 1999-04-30 2002-07-25 Sterix Ltd Use
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
AU2005225148B2 (en) * 1999-04-30 2008-04-03 Sterix Limited Use
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
US6583130B1 (en) 1999-09-13 2003-06-24 Schering Ag C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
DE60023740T2 (de) * 1999-12-13 2006-07-27 Sterix Ltd. Halogenierte sulphamat-, phoshonat-, thiophosphonat-, sulphonat- und sulphonamid- verbindungen als inhibitoren von steroidsulfatase
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
JPWO2001081364A1 (ja) * 2000-04-24 2004-01-08 協和醗酵工業株式会社 エストラ−１，３，５（１０）−トリエン誘導体
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
JP2004521951A (ja) 2001-07-13 2004-07-22 シエーリング アクチエンゲゼルシャフト Ｈｒｔのためのドロスピレノン及びエストロゲンスルファメートの組み合わせ
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
DE10139494A1 (de) * 2001-08-13 2003-03-06 Jenapharm Gmbh Antitumor wirksame 2-Alkoxyestradiolsulfamate
ES2258174T3 (es) 2001-10-18 2006-08-16 Sterix Limited Compuestos esteroideos para la inhibicion de la sulfatasa esteroidea.
EP1448592B1 (en) * 2001-10-18 2006-03-08 Sterix Limited Steroidal compounds for inhibiting steroid sulphatase
US20040254241A1 (en) * 2002-08-28 2004-12-16 Yoji Ino Aryl sulfamate derivatives
US20060035875A1 (en) * 2002-10-09 2006-02-16 Yukimasa Shiotsu Remedy for hormone-dependent cancer
DE10307104A1 (de) 2003-02-19 2004-09-23 Schering Ag Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
DE10307103A1 (de) 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
DE10307105A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
NZ544013A (en) * 2003-05-16 2009-04-30 Theramex Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors
WO2004103971A1 (ja) 2003-05-21 2004-12-02 Aska Pharmaceutical Co., Ltd. 環状アミノフェニルスルファメート誘導体
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
GB0412492D0 (en) 2004-06-04 2004-07-07 Sterix Ltd Compound
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
US8030298B2 (en) 2005-05-26 2011-10-04 Abbott Products Gmbh 17β-HSD1 and STS inhibitors
GB0511190D0 (en) * 2005-06-01 2005-07-06 Sterix Ltd Use
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
GB0624105D0 (en) * 2006-12-01 2007-01-10 Sterix Ltd Use
GB0706072D0 (en) 2007-03-28 2007-05-09 Sterix Ltd Compound
US20100204146A1 (en) 2007-09-17 2010-08-12 Preglem S.A. Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
EP2149371A1 (en) * 2008-07-28 2010-02-03 PregLem S.A. Use of steroid sulfatase inhibitors for the treatment of preterm labor
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
GB0914767D0 (en) 2009-08-24 2009-09-30 Sterix Ltd Compound
CN110974840A (zh) * 2019-12-27 2020-04-10 天津市肿瘤医院 一种类固醇硫酸酯酶抑制剂及其药物用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5700090A (en) * 1989-06-12 1990-12-13 A.H. Robins Company, Incorporated Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE114806C (uk) *
DE1593846A1 (de) * 1967-01-28 1971-02-25 Hoechst Ag Verfahren zur Herstellung von Sulfamidsaeure-arylestern
US3647738A (en) * 1970-11-03 1972-03-07 Union Carbide Corp Alpha-olefin polymer compositions
GB1398026A (en) * 1972-11-10 1975-06-18 Jenapharm Veb Steroid esters
DE2418217A1 (de) * 1974-04-13 1975-11-06 Hoechst Ag Sulfamidsaeureester und verfahren zu ihrer herstellung
DD114806A1 (uk) * 1974-10-11 1975-08-20
US4937237A (en) * 1988-12-23 1990-06-26 Smithkline Beckman Corporation Phosphinic acid substituted aromatic steroids as inhibitors of steroid 5-60 -reductase
GB9003939D0 (en) * 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
GB9625334D0 (en) * 1996-12-05 1997-01-22 Imperial College Compound
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6083978A (en) * 1996-03-05 2000-07-04 Sterix Limited Compounds with a sulfamate group
GB9603325D0 (en) * 1996-02-16 1996-04-17 Imperial College A compound
GB9118465D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
US5880115A (en) * 1997-07-18 1999-03-09 Duquesne University Of The Holy Ghost Steroid sulfatase inhibitors and methods for making and using the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5700090A (en) * 1989-06-12 1990-12-13 A.H. Robins Company, Incorporated Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals

Also Published As

Publication number Publication date
EP1522543A1 (en) 2005-04-13
EP1099706B1 (en) 2004-10-06
NO20044458L (no) 1994-04-29
CY2397B1 (en) 2004-09-10
UA41875C2 (uk) 2001-10-15
CZ44094A3 (en) 1995-01-18
BR9206434A (pt) 1994-09-27
DE69233431T2 (de) 2006-02-23
ES2193475T3 (es) 2003-11-01
HK1025051A1 (en) 2000-11-03
FI940903A0 (fi) 1994-02-25
FI940903A (fi) 1994-04-20
SG106116A1 (en) 2004-09-30
GEP20033094B (en) 2003-10-27
GB9118478D0 (en) 1991-10-16
RU2207134C2 (ru) 2003-06-27
JPH07501515A (ja) 1995-02-16
EP0921130A2 (en) 1999-06-09
DE69233149D1 (de) 2003-09-11
EP0928609B1 (en) 2003-04-16
JP3219408B2 (ja) 2001-10-15
JP2000355598A (ja) 2000-12-26
NO995075D0 (no) 1999-10-18
EP0982032A2 (en) 2000-03-01
GEP20022766B (en) 2002-08-26
GR3034579T3 (en) 2001-01-31
GEP20022802B (en) 2002-09-25
NO314287B1 (no) 2003-03-03
LV12618A (en) 2001-02-20
DK0982032T3 (da) 2003-11-03
EP0928609A2 (en) 1999-07-14
SG103374A1 (en) 2004-04-29
DE69233020T2 (de) 2003-11-06
EP0928609A3 (en) 2001-11-07
HUT66097A (en) 1994-09-28
ATE237333T1 (de) 2003-05-15
KR100321019B1 (ko) 2002-03-20
NO2595A (no) 1994-04-29
SG115508A1 (en) 2005-10-28
NO995076D0 (no) 1999-10-18
GEP20063773B (en) 2006-03-27
JP3581821B2 (ja) 2004-10-27
FI20002260A (fi) 2000-10-13
NO20002595D0 (no) 2000-05-19
NO308774B1 (no) 2000-10-30
SG88782A1 (en) 2002-05-21
RU2210574C2 (ru) 2003-08-20
KR100322650B1 (ko) 2002-03-20
UA70956C2 (uk) 2004-11-15
NO940635D0 (no) 1994-02-24
AU5837396A (en) 1996-09-05
GEP20022803B (en) 2002-09-25
KR100321018B1 (ko) 2002-03-20
DE69231280D1 (de) 2000-08-24
CY2394B1 (en) 2004-09-10
EP0641355A1 (en) 1995-03-08
NO308903B1 (no) 2000-11-13
AU717116B2 (en) 2000-03-16
WO1993005064A1 (en) 1993-03-18
CY2253B1 (en) 2003-07-04
HK1020672A1 (en) 2000-05-19
JP2003176297A (ja) 2003-06-24
EP0982032A3 (en) 2002-03-20
JP2002255993A (ja) 2002-09-11
SK282189B6 (sk) 2001-12-03
ATE278704T1 (de) 2004-10-15
NO995075L (no) 1994-04-29
SK282187B6 (sk) 2001-12-03
EP0921130A3 (en) 2001-09-05
SG73391A1 (en) 2006-08-30
NO940635L (uk) 1994-04-29
ES2204059T3 (es) 2004-04-16
DE69233431D1 (de) 2004-11-11
DK0641355T3 (da) 2000-10-09
US5830886A (en) 1998-11-03
CA2305758A1 (en) 1993-03-18
EP0641355B1 (en) 2000-07-19
ES2148178T3 (es) 2000-10-16
GEP20022637B (en) 2002-02-25
NO307301B1 (no) 2000-03-13
SK24694A3 (en) 1994-11-09
CA2305749A1 (en) 1993-03-18
NO20025725D0 (no) 2002-11-28
DE69233149T2 (de) 2004-06-24
US6159960A (en) 2000-12-12
ATE246706T1 (de) 2003-08-15
FI20050991A (fi) 2005-10-03
JP2000355542A (ja) 2000-12-26
FI20002259A (fi) 2000-10-13
ATE239753T1 (de) 2003-05-15
RU94019334A (ru) 1996-10-20
UA70958C2 (uk) 2004-11-15
CY2398B1 (en) 2004-09-10
HK1019753A1 (en) 2000-02-25
NO20025725L (no) 1994-04-29
SG103820A1 (en) 2004-05-26
ES2196483T3 (es) 2003-12-16
DK0928609T3 (da) 2003-07-21
HU9400583D0 (en) 1994-05-30
ATE194843T1 (de) 2000-08-15
AU2490592A (en) 1993-04-05
SK282188B6 (sk) 2001-12-03
US5616574A (en) 1997-04-01
JP2000038341A (ja) 2000-02-08
JP3581802B2 (ja) 2004-10-27
RU2182152C2 (ru) 2002-05-10
DE69231280T2 (de) 2000-11-30
NO318009B1 (no) 2005-01-17
CA2114630C (en) 2003-09-30
EP1099706A3 (en) 2002-09-04
DE69233020D1 (de) 2003-05-22
NO995076L (no) 1994-04-29
UA70957C2 (uk) 2004-11-15
AU668882B2 (en) 1996-05-23
EP1099706A2 (en) 2001-05-16
CZ295939B6 (cs) 2005-12-14
LV12618B (en) 2001-07-20
DE69233053T2 (de) 2003-11-20
DK0921130T3 (da) 2003-07-21
FI20002261A (fi) 2000-10-13
DE69233053D1 (de) 2003-06-12
EP0921130B1 (en) 2003-05-07
CA2114630A1 (en) 1993-03-18
KR100258396B1 (ko) 2000-08-01
EP0982032B1 (en) 2003-08-06
JP3581820B2 (ja) 2004-10-27
CA2305767A1 (en) 1993-03-18
AU689043B2 (en) 1998-03-19
AU1007799A (en) 1999-03-04
SK282186B6 (sk) 2001-12-03
RU2001125673A (ru) 2003-06-27

Similar Documents

Publication Publication Date Title
AU689043B2 (en) Steroid sulphatase inhibitors